Morgan Creek - Exos Active SPAC Arbitrage ETF
CSH was delisted on the 11th of April, 2023.
4 hedge funds and large institutions have $4.84M invested in Morgan Creek - Exos Active SPAC Arbitrage ETF in 2022 Q3 according to their latest regulatory filings, with 1 funds opening new positions, 2 increasing their positions, 1 reducing their positions, and closing their positions.
100% more repeat investments, than reductions
Existing positions increased: 2 | Existing positions reduced: 1
0% more capital invested
Capital invested by funds: $4.84M → $4.84M (+$9K)
0% more funds holding
Funds holding: 4 → 4 (0)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
CS
Credit Suisse
Zurich,
Switzerland
|
+$151K |
| 2 |
LFASL
Lugano Financial Advisors SA (LFA)
Lugano,
Switzerland
|
+$131K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
UBS Group
Zurich,
Switzerland
|
-$2.28K |
CSH Hedge Fund Activity: Q3 2022 in Review
4 of the 5,805 institutional investors tracked by Wall St. Rank reported a position in Morgan Creek - Exos Active SPAC Arbitrage ETF (CSH) for Q3 2022, worth a combined $4.84M — up 0.19% from $4.84M a quarter earlier.
Buyers outnumbered sellers: 1 fund opened new CSH positions and 0 closed out — a net gain of 1 holder — while 2 added to existing stakes and 1 trimmed.
The largest buyer was Credit Suisse, adding an estimated $151K. The largest seller was UBS Group, cutting an estimated $2.28K.
- 4 institutional investors held Morgan Creek - Exos Active SPAC Arbitrage ETF (CSH) as of Q3 2022, unchanged from Q2 2022.
- Funds reported $4.84M of Morgan Creek - Exos Active SPAC Arbitrage ETF stock for Q3 2022, up 0.19% quarter-over-quarter.
- 1 fund opened new Morgan Creek - Exos Active SPAC Arbitrage ETF positions in Q3 2022 and 0 closed out, a net change of +1 holder.
- The largest Morgan Creek - Exos Active SPAC Arbitrage ETF buyer in Q3 2022 was Credit Suisse, an estimated $151K added.
- The largest Morgan Creek - Exos Active SPAC Arbitrage ETF seller in Q3 2022 was UBS Group, an estimated $2.28K sold.
Based on aggregated 13F filings for Q3 2022.